Delivery Order SPE2DB22D1106-SPE2DB24FEQV1
Award Date
5/8/24
Potential Completion Date
5/9/24
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Aimovig 140 mg/mL Autoinjector, awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for the supply of AIMOVIG 140 MG/ML autoinjectors to the Defense Logistics Agency (DLA). The $7,244.57 firm fixed-price contract has a completion date of February 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,088.07 delivery order is under a larger, single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which expires on December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML to the U.S. government. The contract has a ceiling value of $2,715.72 and is a Delivery Order under a Firm Fixed Price contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) by the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of AIMOVIG 70 MG/ML autoinjectors. The $1,745.07 fixed-price contract has a completion date of November 8, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the medication AIMOVIG 140 MG/ML AUTOINJECTORML to the Defense Logistics Agency (DLA). The contract, valued at $1,050.38, is a firm-fixed price delivery order with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $2,715.72, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corporation's Corporate Office Division. The award is for the delivery of AIMOVIG 140 MG/ML autoinjectors, a specialty pharmaceutical product, with a completion date of May 23, 2024. This order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,988.96 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a completion date of June 12, 2024. This Delivery Order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $11,229.48 Firm Fixed Price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication, with a performance period through December 20, 2024. Amerisourcebergen holds a $999,999,999 IDC with the DLA for providing a comprehensive range of pharmaceutical...